Martin J. Whitaker

2.9k total citations
50 papers, 2.2k citations indexed

About

Martin J. Whitaker is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Martin J. Whitaker has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Molecular Biology and 14 papers in Biomedical Engineering. Recurrent topics in Martin J. Whitaker's work include Adrenal Hormones and Disorders (26 papers), Sexual Differentiation and Disorders (20 papers) and Hormonal Regulation and Hypertension (10 papers). Martin J. Whitaker is often cited by papers focused on Adrenal Hormones and Disorders (26 papers), Sexual Differentiation and Disorders (20 papers) and Hormonal Regulation and Hypertension (10 papers). Martin J. Whitaker collaborates with scholars based in United Kingdom, Germany and United States. Martin J. Whitaker's co-authors include Steven M. Howdle, Kevin M. Shakesheff, Richard Ross, Owen R. Davies, Robin A. Quirk, Wiebke Arlt, Andrew L. Lewis, Miguel Debono, Hongyun Tai and В. К. Попов and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Martin J. Whitaker

50 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin J. Whitaker United Kingdom	24	858	573	536	512	474	50	2.2k
Hongyun Tai United Kingdom	25	767 0.9×	53 0.1×	824 1.5×	277 0.5×	746 1.6×	53	2.2k
Janet A. Tamada United States	21	1.1k 1.3×	506 0.9×	546 1.0×	417 0.8×	110 0.2×	26	3.2k
Qian Xu China	31	790 0.9×	103 0.2×	742 1.4×	620 1.2×	198 0.4×	99	2.8k
Guiting Liu China	30	1.1k 1.3×	190 0.3×	1.3k 2.4×	346 0.7×	218 0.5×	55	3.0k
Zhongkui Hong United States	33	1.8k 2.1×	47 0.1×	1.6k 2.9×	340 0.7×	306 0.6×	53	3.3k
Xue Qu China	25	799 0.9×	30 0.1×	784 1.5×	208 0.4×	136 0.3×	54	2.0k
Petek Korkusuz Türkiye	30	985 1.1×	116 0.2×	757 1.4×	597 1.2×	46 0.1×	158	2.8k
Xin Jiang China	27	532 0.6×	33 0.1×	354 0.7×	575 1.1×	304 0.6×	70	2.3k
Ueon Sang Shin South Korea	29	1.7k 1.9×	23 0.0×	834 1.6×	418 0.8×	289 0.6×	92	3.4k

Countries citing papers authored by Martin J. Whitaker

Since Specialization

Citations

This map shows the geographic impact of Martin J. Whitaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin J. Whitaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin J. Whitaker more than expected).

Fields of papers citing papers by Martin J. Whitaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin J. Whitaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin J. Whitaker. The network helps show where Martin J. Whitaker may publish in the future.

Co-authorship network of co-authors of Martin J. Whitaker

This figure shows the co-authorship network connecting the top 25 collaborators of Martin J. Whitaker. A scholar is included among the top collaborators of Martin J. Whitaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin J. Whitaker. Martin J. Whitaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michelet, Robin, Uta Neumann, Oliver Blankenstein, et al.. (2024). A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapy. Journal of Pharmacokinetics and Pharmacodynamics. 51(6). 809–824. 2 indexed citations

Neumann, Uta, Oliver Blankenstein, Peter C. Hindmarsh, et al.. (2023). Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients. Pharmaceuticals. 16(3). 464–464. 2 indexed citations

Whitaker, Martin J., Miguel Debono, & Richard Ross. (2023). Developing oral chronotherapy for cortisol replacement in congenital adrenal hyperplasia. Clinical Endocrinology. 101(4). 311–317. 6 indexed citations

Whitaker, Martin J., Hiep Huatan, & Richard Ross. (2022). Chronotherapy based on modified-release hydrocortisone to restore the physiological cortisol diurnal rhythm. Drug Delivery and Translational Research. 13(1). 1–8. 8 indexed citations

Neumann, Uta, Oliver Blankenstein, Richard Ross, et al.. (2022). Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis. Frontiers in Pharmacology. 13. 819590–819590. 6 indexed citations

Burt, Howard, et al.. (2021). Development and verification of an endogenous PBPK model to inform hydrocortisone replacement dosing in children and adults with cortisol deficiency. European Journal of Pharmaceutical Sciences. 165. 105913–105913. 16 indexed citations

Nikolaou, Nikolaos, Anastasia Arvaniti, Beverly Hughes, et al.. (2020). Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo. Journal of Endocrinology. 245(2). 207–218. 8 indexed citations

Daniel, Eleni, Martin J. Whitaker, Brian Keevil, J K Wales, & Richard Ross. (2018). Accuracy of hydrocortisone dose administration via nasogastric tube. Clinical Endocrinology. 90(1). 66–73. 8 indexed citations

Jenkins‐Jones, Sara, John B. Porter, Martin J. Whitaker, et al.. (2018). Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia. European Journal of Endocrinology. 178(4). 309–320. 54 indexed citations

10.

Whitaker, Martin J., et al.. (2018). Biorelevant in vitro assessment of dissolution and compatibility properties of a novel paediatric hydrocortisone drug product following exposure of the drug product to child-appropriate administration fluids. European Journal of Pharmaceutics and Biopharmaceutics. 133. 277–284. 13 indexed citations

11.

Neumann, Uta, Martin J. Whitaker, Susanna Wiegand, et al.. (2017). Absorption and tolerability of taste‐masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. Clinical Endocrinology. 88(1). 21–29. 42 indexed citations

12.

Neumann, Uta, et al.. (2017). Quality of compounded hydrocortisone capsules used in the treatment of children. European Journal of Endocrinology. 177(2). 239–242. 41 indexed citations

13.

Whitaker, Martin J., et al.. (2017). Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia. European Journal of Endocrinology. 176(4). 405–411. 5 indexed citations

14.

Jones, Christopher M., Ashwini Mallappa, Nicole Reisch, et al.. (2016). Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 102(6). jc.2016–2855. 43 indexed citations

15.

Perinelli, Diego Romano, Marco Cespi, Giulia Bonacucina, et al.. (2016). PEGylated Biodegradable Polyesters for PGSS Microparticles Formulation: Processability, Physical and Release Properties. Current Drug Delivery. 13(5). 673–681. 8 indexed citations

16.

Mallappa, Ashwini, Ninet Sinaii, Parag Kumar, et al.. (2014). A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 100(3). 1137–1145. 106 indexed citations

17.

Durrant, LG, Ian Spendlove, Steven M. Howdle, et al.. (2011). Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology. International Journal of Pharmaceutics. 413(1-2). 147–154. 23 indexed citations

18.

Davies, Owen R., Andrew L. Lewis, Martin J. Whitaker, et al.. (2007). Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering. Advanced Drug Delivery Reviews. 60(3). 373–387. 227 indexed citations

19.

Ginty, Patrick, Daniel J. Howard, Felicity R. A. J. Rose, et al.. (2006). Mammalian cell survival and processing in supercritical CO ₂. Proceedings of the National Academy of Sciences. 103(19). 7426–7431. 36 indexed citations

20.

Антонов, Е. Н., В. Н. Баграташвили, Martin J. Whitaker, et al.. (2004). Three‐Dimensional Bioactive and Biodegradable Scaffolds Fabricated by Surface‐Selective Laser Sintering. Advanced Materials. 17(3). 327–330. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact